A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

December 23, 2024

Study Completion Date

December 23, 2024

Conditions
Adult Growth Hormone DeficiencyEndocrine System DiseasesHormone Deficiency
Interventions
DRUG

Lonapegsomatropin

Study participants are individually dosed with subcutaneous injection of Lonapegsomatropin once-weekly for 52 weeks

Trial Locations (85)

2065

Ascendis Pharma Investigational Site, Saint Leonards

2109

Ascendis Pharma Investigational Site, Sydney

3010

Ascendis Pharma Investigational Site, Alicante

3050

Ascendis Pharma Investigational Site, Parkville

3065

Ascendis Pharma Investigational Site, Fitzroy

3128

Ascendis Pharma Investigational Site, Box Hill

3491

Ascendis Pharma Investigational Site, Ľubochňa

6009

Ascendis Pharma Investigational Site, Perth

8035

Ascendis Pharma Investigational Site, Barcelona

8041

Ascendis Pharma Investigational Site, Barcelona

10017

Ascendis Pharma Investigational Site, New York

10450

Ascendis Pharma Investigational Site, George Town

11000

Ascendis Pharma Investigational Site, Belgrade

11527

Ascendis Pharma Investigational Site, Athens

11868

Ascendis Pharma Investigational Site, Bucharest

13385

Ascendis Pharma Investigational Site, Marseille

16132

Ascendis Pharma Investigational Site, Genova

21010

Ascendis Pharma Investigational Site, Vinnytsia

31048

Ascendis Pharma Investigational Site, Haifa

38039

Ascendis Pharma Investigational Site, Kayseri

41001

Ascendis Pharma Investigational Site, İzmit

41013

Ascendis Pharma Investigational Site, Seville

44093

Ascendis Pharma Investigational Site, Nantes

46202

Ascendis Pharma Investigational Site, Indianapolis

48126

Ascendis Pharma Investigational Site, Dearborn

54636

Ascendis Pharma Investigational Site, Thessaloniki

55905

Ascendis Pharma Investigational Site, Rochester

60611

Ascendis Pharma Investigational Site, Chicago

62250

Ascendis Pharma Investigational Site, Putrajaya

63110

Ascendis Pharma Investigational Site, St Louis

69677

Ascendis Pharma Investigational Site, Lyon

75390

Ascendis Pharma Investigational Site, Dallas

75400

Ascendis Pharma Investigational Site, Malacca

76008

Ascendis Pharma Investigational Site, Ivano-Frankivsk

78232

Ascendis Pharma Investigational Site, San Antonio

80336

Ascendis Pharma Investigational Site, München

82606

Ascendis Pharma Investigational Site, Bratislava

85048

Ascendis Pharma Investigational Site, Phoenix

89148

Ascendis Pharma Investigational Site, Las Vegas

89511

Ascendis Pharma Investigational Site, Reno

90509

Ascendis Pharma Investigational Site, Torrance

97239

Ascendis Pharma Investigational Site, Portland

98108

Ascendis Pharma Investigational Site, Seattle

700106

Ascendis Pharma Investigational Site, Iași

4941480

Ascendis Pharma Investigational Site, Petah Tikva

6423906

Ascendis Pharma Investigational Site, Tel Aviv

02114

Ascendis Pharma Investigational Site, Boston

0075

Ascendis Pharma Investigational Site, Yerevan

B3H 1V7

Ascendis Pharma Investigational Site, Halifax

0144

Ascendis Pharma Investigational Site, Tbilisi

0159

Ascendis Pharma Investigational Site, Tbilisi

00161

Ascendis Pharma Investigational Site, Rome

00168

Ascendis Pharma Investigational Site, Rome

650-0047

Ascendis Pharma Investigational Site, Kobe

216-8511

Ascendis Pharma Investigational Site, Kawasaki

222-0036

Ascendis Pharma Investigational Site, Yokohama

260-8677

Ascendis Pharma Investigational Site, Chiba

812-8582

Ascendis Pharma Investigational Site, Fukuoka

920-0293

Ascendis Pharma Investigational Site, Ishikawa

890-8520

Ascendis Pharma Investigational Site, Kagoshima

210-0024

Ascendis Pharma Investigational Site, Kawasaki

211-8533

Ascendis Pharma Investigational Site, Kawasaki

807-8555

Ascendis Pharma Investigational Site, Kitakyushu

390-8510

Ascendis Pharma Investigational Site, Matsumoto

534-0021

Ascendis Pharma Investigational Site, Miyakojima

480-1195

Ascendis Pharma Investigational Site, Nagakute

634-8522

Ascendis Pharma Investigational Site, Nara

700-8558

Ascendis Pharma Investigational Site, Okayama

550-0006

Ascendis Pharma Investigational Site, Osaka

422-8527

Ascendis Pharma Investigational Site, Shizuoka

565-0871

Ascendis Pharma Investigational Site, Suita

990-9585

Ascendis Pharma Investigational Site, Yamagata

236-0004

Ascendis Pharma Investigational Site, Yokohama

31-501

Ascendis Pharma Investigational Site, Krakow

93-338

Ascendis Pharma Investigational Site, Lodz

03-242

Ascendis Pharma Investigational Site, Warsaw

50-367

Ascendis Pharma Investigational Site, Wroclaw

06591

Ascendis Pharma Investigational Site, Soeul

06560

Ascendis Pharma Investigational Site, Ankara

07070

Ascendis Pharma Investigational Site, Antalya

09010

Ascendis Pharma Investigational Site, Aydin

03115

Ascendis Pharma Investigational Site, Kyiv

04001

Ascendis Pharma Investigational Site, Kyiv

04114

Ascendis Pharma Investigational Site, Kyiv

LS9 7TF

Ascendis Pharma Investigational Site, Leeds

All Listed Sponsors
lead

Ascendis Pharma Endocrinology Division A/S

INDUSTRY

NCT05171855 - A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency | Biotech Hunter | Biotech Hunter